Director, Translational Pathology — Biomarker Strategy

AstraZeneca GmbH; Cambridge; On-site; GBP 120,000 - 180,000; Full time

Benefits offered by this job

Flexible benefits fund

Holiday purchase

Pension contributions

Share Save Plans

Performance recognition

Job summary

AstraZeneca Cambridge is seeking a Director, Translational Pathology to lead the scientific quality and delivery of the Translational Pathology portfolio. The role combines portfolio oversight, line management, project leadership, and cross-functional collaboration with autonomy in decision-making.

Responsibilities include leading tissue-based biomarker strategies, histopathology leadership, and ensuring GCP and QA compliance across studies while partnering with multiple functions to enable

Qualifications

• Significant postdoctoral experience in a related field.

Responsibilities

• Provide scientific leadership across the Translational Pathology portfolio.
• Act as an expert in histopathology, tissue-based biomarkers, immunohistochemistry, digital pathology and image analysis.
• Develop and challenge experimental plans, work packages, assay strategies, controls, endpoints, sample requirements and analytical approaches.
• Maintain an integrated view of project scope, milestones, risks and delivery across active and planned work.
• Lead scientific projects or workstreams, contributing to design, data interpretation and delivery of high-quality outputs.
• Ensure pathology activities align with GCP/quality standards and company procedures.

Skills

Histopathology expertise

Immunohistochemistry

Leadership

Cross-functional collaboration

Scientific data analysis

Education

Postdoctoral experience

Tools

Digital pathology software

Image analysis tools

Job description

AstraZeneca Cambridge is seeking a Director, Translational Pathology to lead the scientific quality and delivery of the Translational Pathology portfolio. The role combines portfolio oversight, line management, project leadership, and cross-functional collaboration with autonomy in decision-making.

Responsibilities include leading tissue-based biomarker strategies, histopathology leadership, and ensuring GCP and QA compliance across studies while partnering with multiple functions to enable